## Abstract ## BACKGROUND. Venous thromboembolism (VTE) contributes to morbidity and mortality in cancer patients and is a frequent complication of anticancer therapy. In the current study, the frequency, risk factors, and trends associated with VTE were examined among hospitalized cancer patients
Risk factor model to predict venous thromboembolism in hospitalized medical patients
β Scribed by Michael B. Rothberg; Peter K. Lindenauer; Maureen Lahti; Penelope S. Pekow; Harry P. Selker
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 213 KB
- Volume
- 6
- Category
- Article
- ISSN
- 1553-5592
- DOI
- 10.1002/jhm.888
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
BACKGROUND:
The Joint Commission requires that all medical inpatients be assessed for venous thromboembolism (VTE) risk, but available risk stratification tools have never been validated.
METHODS:
We conducted a retrospective cohort study of patients age β₯18 years, admitted to 374 US hospitals in 2004β2005, with a primary diagnosis of pneumonia, heart failure, chronic obstructive pulmonary disease (COPD), stroke, and urinary tract infection, and length of stay β₯3 days. Subjects were randomly assigned (80/20) to a derivation or validation set. We then assessed VTE (International Classification of Diseases, Ninth Revision [ICDβ9] code plus diagnostic test plus treatment), patient demographics, 21 potential risk factors, and other comorbidities. We created a VTE risk stratification tool using multivariable regression modeling and applied it to the validation sample.
RESULTS:
Of 242,738 patients, 612 (0.25%) patients fulfilled our criteria for VTE during hospitalization, and an additional 440 (0.18%) were readmitted for VTE within 30 days (overall incidence of 0.43%). In the multivariable model, age, sex, and 10 additional risk factors were associated with VTE. The strongest risk factors were inherited thrombophilia (OR 4.00), length of stay β₯6 days (OR 3.22), inflammatory bowel disease (OR 3.11), central venous catheter (OR 1.87), and cancer. In the validation set, the model had a cβstatistic of 0.75 (95% CI 0.71, 0.78). Deciles of predicted risk ranged from 0.11% to 1.46% with observed risk over the same deciles from 0.17% to 1.81%.
CONCLUSIONS:
The risk of symptomatic VTE in general medical patients is low. A risk factor model can identify those at sufficient risk to warrant pharmacologic prophylaxis. Journal of Hospital Medicine 2011. Β© 2011 Society of Hospital Medicine.
π SIMILAR VOLUMES
Frequency, Risk Factors, and Trends for Venous Thromboembolism Among Hospitalized Cancer Patients I n a recent issue of Cancer, Khorana et al. 1 concluded that venous thromboembolic events (VTEs) are an increasingly frequent complication of hospitalization in cancer patients. We strongly agree with
Frequency, Risk Factors, and Trends for Venous Thromboembolism Among Hospitalized Cancer Patients I n a recent issue of Cancer, Khorana et al. 1 concluded that venous thromboembolic events (VTEs) are an increasingly frequent complication of hospitalization in cancer patients. We strongly agree with
## Abstract ## BACKGROUND: Peripherally inserted central catheters (PICC) are increasingly used in hospitalized patients. The benefit can be offset by complications such as upper extremity deep vein thrombosis (UEDVT). ## METHODS: Retrospective study of patients who received a PICC while hospita
## Abstract ## BACKGROUND Venous thromboembolism (VTE) is a common cause of morbidity and mortality among patients with malignant gliomas. To investigate the pathogenesis of VTE and facilitate targeted prophylaxis strategies, the authors aimed to characterize VTE risk factors in these patients. #
Venous thromboembolism (VTE) is common but often unrecognized in medically ill patients. Over the past 5 years, three large-scale placebo-controlled trials enrolling a total of 5500 medically ill patients have highlighted the risk of VTE in this group. These trials have helped to define a specific a